Oligomeric proanthocyanidins extracted from the bark of the French maritime pine Pinus pinaster (FMPBE) have been studied for a long time and demonstrated various phytopharmaceutical applications. The objectives of this study were to assess the cutaneous lightening and anti-ageing effects of FMPBE after 56 days of consumption, in healthy Asian women. The cosmetic efficacy of the product was assessed through various biometrological evaluations. This randomised, double-blind, placebocontrolled and cross-over study evidenced the safety and efficacy of the 100 mg FMPBE supplementation from 28 days of intake: in comparison to placebo, the skin on pigmentary spots became significantly lighter and less red, skin on the face was more firm and its surface was less wrinkled. After 56 days of consumption, the skin was additionally significantly more elastic and the yellow constituent of the skin decreased on the normal skin. Taken together, these results proved that FMPBE supplementation can be considered as an innovative approach to skin whitening and anti-ageing treatments. It represents an interesting alternative to topical products and supports the skin from the inside out.
Introduction
Polyphenols are a wide range of biological molecules which play a protective role in plants. They Later, thanks to their strong antioxidant properties, more studies were carried out on OPCs in the nutrition and preventive medicine area [3] .
OPCs extracted from the bark of the French maritime pine Pinus pinaster have been studied for a long time (for review, see [4, 5] A randomised, double-blind, placebo-controlled, cross-over design was employed for this study. It took place at Dermscan Asia (Bangkok, Thailand). The study was conducted in compliance with Good Clinical Practices.
Subjects
The minimum planned number of subjects to be analysed was 30. In order to participate in the study, women had to over 45 years old and Asian with phototype IV or V. They had to present slight wrinkles or fine lines on crow's feet and at least two pigmentation spots on face and/or hands and/or cleavage. The consumption of food supplements in the two previous months or during the study was forbidden. Subjects with an unbalanced weight or using any topical or systemic treatment likely to interfere with the assessment of the efficacy evaluation were excluded. Intensive exposure to sunlight or UV rays within the previous month or foreseen during the study were not accepted. Subject's participation in the study came into effect only after providing full informed consent. All procedures followed were in accordance with the ethical stan- mg maltodextrin (71.4%) and 30 mg magnesium stearate (10.7%). The active ingredient used in this study is a purified extract from FMPB (P. pinaster, Aiton). It is obvious that, according to the extraction process used, one can obtain many finished products, even when using the same raw material, leading to differing chemical composition and biological activity [11] . Chemical composition of the present product has been established using different analytical techniques, including HPLC, gel permeation power, especially in the human low-density lipoprotein model [6] . A study evaluated the effect of longterm supplementation with FMPBE on rats and Syrian hamsters, especially on plasma antioxidant activity and atherosclerosis prevention [7] . FMPBE showed no toxicity and no side effects during the period of experimentation. Also, it did not have any influence on daily intake. FMPBE was absorbed and induced measurable biological activity. FMPBE improved the resistance of the heart against free radical oxidation. OPCs were more active and most probably more bioavailable than high-molecular-weight tannins and had an effective and strong protective antioxygen free radical activity. There was a significant reduction of oxidized lipids at the surface of the arteries (atherosclerotic arteries) in the group supplemented with FMPBE. FMPBE also prevents chronic UVB radiation-induced skin damage and carcinogenesis in melanin-possessing hairless mice [8] .
A clinical study assessed the effect of a daily dosage of 80 mg of FMPBE on melasma (40 mg twice a day) [9] . The results clearly showed an improvement both on skin lightening and melasma reduction after one month. In 2005, another clinical study showed good results in the evaluation of the effect of a blend of ingredients including FMPBE on skin beauty (mainly anti-wrinkle and skin elasticity) [10] . FMPBE, as shown by in vitro and in vivo testing and clinical studies, has been used in health and beauty food supplements and functional food products, providing interesting biological effects, without side effects [5] . The aim of this study was to precisely quantify the effect of FMPBE on skin beauty: whitening, anti-dark spot, anti-wrinkle and skin biomechanical properties.
Materials and methods

Experimental plan
The objectives of this study were to assess the cutaneous lightening and anti-ageing effects of a pine bark extract after 56 days of consumption in healthy women. The cosmetic efficacy of the product was assessed through various biometrological evaluations. Nutrafoods (2014) lection of the spots checked with the subjects that they were not some nevus or any other birthmark, to select only lentigo senile. Measurements of skin colour with a Minolta CM700d spectrophotometer were performed on the three defined areas. A skinprint was performed on one defined crow's foot in order to evaluate skin relief parameters using a Skin Image Analyser ® (SIA ® ) and QuantiRides ® software.
Biomechanical cutaneous properties on the defined crow's foot were measured with a Cutometer ® . A macrophotograph of each pigmentary spot was taken and the first treatment (active or placebo) was distributed to the subjects according to the randomisation list. Women had to take one capsule in the morning and one in the evening. A daily log was also provided in order to register any concomitant treatment or adverse events.
Day 28: the subjects came back to the laboratory with their treatment and completed a daily log.
The same measurements were performed as on D0, on the same zones. The product was distributed again to the subjects as well as a new daily log.
Day 56: The subjects came back to the laboratory with their products and completed a daily log. The same measurements were performed as on D0, on the same zones.
After a wash-out period of 14 days, during which the subjects did not have to take any test products, the women came back for the second period of trial.
Period 2
Day 0: The same measurements were performed as the ones in Period 1 on D0, on the same zones (skin colour on back and pigmentary spots, biomechanical cutaneous properties and skinprint in crow's foot, macrophotographs on pigmentary spots). The second treatment (active or placebo) was distributed to the subjects according to the randomisation list. Women had to take one capsule in the morning and one in the evening. A daily log was also provided in order to register any concomitant treatment or adverse events.
On D28 and D56, the subjects came back to the chromatography, mass spectrometry, NMR and chemical tests (Bate-Smith, Folin, vanillin test). According to these different methods, the composition of the product was defined (Table 1) .
Each placebo capsule contained (% by weight) 250 mg maltodextrin (89.3%) and 30 mg magnesium stearate (10.7%). These capsules were identical in shape, smell, taste and weight to the active capsules. The dosage of 100 mg/day of FMPBE tested in this study corresponded to less than 1/500th of the no observed adverse effect limit (NOAEL). This selected dosage (100 mg/day) was in accordance with some previous clinical studies: one clinical study demonstrated the effect of FMPBE at 80 mg/day [12] for melasma treatment. Furumura et al. [13] used it at 100 mg/day and Saliou et al. [14] used it at 1.10 mg/kg/day. The skin is sucked into the orifice of a probe by constant vacuum pressure (300 mbar) for 3 s followed by a 2-s relaxation period. The depth to which the skin penetrates into the probe is measured by two optical prisms located at the opening of the probe's orifice. These measurements define different parameters characterising the biomechanical properties of tegument:
• Firmness (parameter R0): A decrease of this parameter means firmer skin
• Elasticity (parameters R2, R5 or R7): An increase of one of these parameters indicates more elastic skin. Parameter R6 is also representative of the state of skin elasticity: its decrease characterises more elastic skin.
• Fatigability (parameter R9): A decrease of this parameter indicates an improvement of the cutaneous state.
Macrophotography
The digital camera used was a Nikon D100 or D70.
The photographs were taken in standardised, indirect light. Aperture, speed and distance of the camera were also standardised. The control of the repositioning took place directly on a data-processing screen thanks to simultaneous visualisation of the images at various times of acquisition.
Statistics
For each studied parameter (spectrophotometer and Cutometer ® measurements, wrinkle analysis) and for laboratory with their treatment and completed daily log. The same measurements as on D0 in Period 1 were performed, on the same zones.
Evaluation tools
CM700d spectrophotometer (Minolta)
Skin colorimetric measurements were performed with apparatus equipped with a 3 mm diameter head. The device converts colours perceived by humans to a digital code composed of three parame- When comparing the two treatments on D56, the FMPBE significantly decreased the yellow constituent of the skin (b* parameter) compared to placebo (p= 0.097).
Skin colour evaluation on pigmentary spots (see Table 3 )
Already after 28 days of FMPBE intake, L* and ITA°p arameters were significantly increased and a* was significantly decreased reflecting a significant lightening effect of the skin and a decrease of the red cutaneous pigmentation on spots. Regarding placebo consumption, skin appeared significantly more red on spots after 56 days of intake (a* parameter; p=0.047). 
Results
Thirty-five women were included in the study but one subject did not come for the visit on D28 and was therefore dropped from the study. Thirty-four women, with a mean age of 60±1 years (46-70 years), completed the study. Both treatments were very well tolerated, with no declared adverse effects after 56 days of intake.
Skin colour evaluation on normal skin (back) (see Table 2 )
After 56 days of FMPBE intake, L* and ITA° parameters significantly increased (p=0.076 and p=0.016 respectively), reflecting a significant lightening effect of the skin and a decrease of the cutaneous pigmentation on the back. The b* parameter also signifiNutrafoods (2014) These results characterise an anti-wrinkle effect of FMPBE after 28 days of intake. The anti-wrinkle effect was measured in approximately 65%-71% of the subjects.
Fifty-six days of placebo consumption induced a significant reduction of -2% on average in the depth of microrelief furrows (p=0.087), meaning smoother skin, without anti-wrinkle effect. This smoothing activity was observed on 62% of the subjects.
Evaluation of cutaneous biomechanical
properties on the temple (data not shown)
After 28 days and 56 days of FMPBE intake and in comparison with the initial state:
• Skin firmness was significantly increased (mean variations of -8% after 28 days, p<0.001; and -7% after 56 days, p<0.001). The improvement of skin firmness was statistically different from the placebo group (p=0.014 on D28 and p=0.014 on D56).
• Skin elasticity was significantly improved on D56 (mean variations of +3%, p=0.057 for R2
parameter and +4%, p=0.066 for R7 parameter).
• Skin fatigability was significantly decreased (mean variations of -9% after 28 days, p=0.002
and -9% after 56 days, p=0.028). The reduction of skin fatigability was statistically different from the placebo group on D28 (p=0.028).
No significant variation of rheological characteristics of the skin was registered with the placebo treatment.
Macrophotographies
An example of results obtained with FMPBE on pigmentary spots is presented in Fig. 1 .
Discussion
Within Asia, the population 65 years and older is expected to grow dramatically over the next 50 years. As a whole, this age group is expected to grow by 314% in Asia: going from 207 million in pigmentary spots. It stayed significantly lighter (ITA°p arameter) and less red (a*) after 56 days of intake.
Wrinkle evaluation on crow's foot skinprint (see Table 4 )
Under these study conditions, FMPBE induced the following:
• A significant decrease in the total wrinkled surface of -15% on average (p=0.026) after 28 days of product intake. This effect was significantly different from the placebo effect (p=0.003) after 28 days and less significantly different after 56 days (p=0.108).
• A significant decrease in the number of medium wrinkles of -12% on average (p=0.075) after 28 days of product intake.
• A significant decrease in the depth of deep wrinkles after 28 and 56 days of product intake of Nutrafoods (2014) lighter and less red, skin on the face was more firm and its surface was less wrinkled. After 56 days of consumption, the skin was additionally significantly more elastic and the yellow constituent of the skin was decreased on the normal skin.
In this study, the levels of efficacy obtained thanks to oral supplementation were comparable to or better than the results that could be achieved with topical application. Furthermore, significant changes appeared already after 28 days of consumption, corresponding to rapid action. The cutaneous changes obtained in the presence of FMPBE could be the result of combined activities: it traps lipid peroxides and free radicals, and it also chelates to free iron molecules, so as to inhibit iron-induced lipid peroxidation; it non-competitively inhibits xanthine oxidase, a major generator of free radicals [3, 18] .
FMPBE prevents the release of pro-inflammatory mediators regulated by oxidative stress [14, 15, 19] .
As UV radiation is a major source of reactive oxygen species leading to oxidative stress, inflammation and pigmentary disorders, FMPBE is indicated to counteract UV-induced damage. The lightening effect obtained in this study on both pigmentary spots and normal skin is in accordance with previous observations on photoaged facial skin in the presence of a FMPBE supplementation [13] or UV-induced skin damage [14] . It was shown in vitro that OPCs from either FMPBE or grapeseed influence the NF-κB signalling pathway activated by UV-induced oxidative stress [14, 20] . The firming and anti-wrinkle effects measured from 28 days of supplementation should be linked to FMPBE anti-inflammatory properties and its capacity of inhibition of enzymes degrading connective tissue structures (hyaluronidase, elastase, collagenase, gelatinase) [21, 22] . It could be also (ii) at the dermal level, they slow down dermal components' degradation and stimulate their synthesis.
They also favour fibroblast renewal and water retention and maintain fundamental theme volume.
Some of the well known actives used are retinol, vitamin C, hyaluronic acid and α-hydroxy acids.
Whitening care products, leading to an overall skin lightening effect, were first aimed at Asian women.
Nowadays, Western markets are also interested in these products, combating localised hyperpigmentation and dull complexion. Most whitening agents use inhibitors of tyrosinase, a key enzyme in melanogenesis, or the activity of its mediators. Topical products designed today for skin lightening mainly employ arbutin, kojic acid or azelaic acid. These ingredients are often associated with antioxidants, agents promoting desquamation and sunscreens.
Here, very strict trial conditions were set up in order to assess the skin lightening and anti-ageing Nutrafoods (2014) 
